MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 235 filers reported holding MYRIAD GENETICS INC in Q3 2015. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $6,246,000 | -7.3% | 204,267 | -7.7% | 0.01% | -12.5% |
Q1 2021 | $6,737,000 | +14.7% | 221,254 | -25.5% | 0.01% | 0.0% |
Q4 2020 | $5,875,000 | +42.0% | 297,076 | -6.3% | 0.01% | +33.3% |
Q3 2020 | $4,136,000 | -14.1% | 317,176 | -25.3% | 0.01% | -25.0% |
Q2 2020 | $4,816,000 | -31.0% | 424,729 | -12.9% | 0.01% | -46.7% |
Q1 2020 | $6,975,000 | -37.7% | 487,418 | +18.6% | 0.02% | -25.0% |
Q4 2019 | $11,192,000 | -59.1% | 411,018 | -57.0% | 0.02% | -31.0% |
Q3 2019 | $27,364,000 | +126.2% | 955,768 | +119.5% | 0.03% | +11.5% |
Q2 2019 | $12,095,000 | +13.1% | 435,384 | +35.2% | 0.03% | +8.3% |
Q1 2019 | $10,694,000 | +71.9% | 322,096 | +50.5% | 0.02% | +50.0% |
Q4 2018 | $6,221,000 | -13.2% | 213,996 | +37.4% | 0.02% | +6.7% |
Q3 2018 | $7,167,000 | +11.2% | 155,796 | -9.7% | 0.02% | 0.0% |
Q2 2018 | $6,446,000 | +314.8% | 172,496 | +228.0% | 0.02% | +275.0% |
Q1 2018 | $1,554,000 | -69.3% | 52,596 | -64.3% | 0.00% | -69.2% |
Q4 2017 | $5,055,000 | +14.2% | 147,196 | +20.3% | 0.01% | 0.0% |
Q3 2017 | $4,428,000 | +70.8% | 122,396 | -3.9% | 0.01% | +62.5% |
Q2 2017 | $2,593,000 | +14.6% | 127,396 | +8.1% | 0.01% | +14.3% |
Q1 2017 | $2,262,000 | +17.4% | 117,796 | +1.9% | 0.01% | 0.0% |
Q4 2016 | $1,927,000 | +56.0% | 115,596 | +92.7% | 0.01% | +40.0% |
Q3 2016 | $1,235,000 | -36.1% | 59,996 | +5.3% | 0.01% | -37.5% |
Q2 2016 | $1,932,000 | +110.7% | 56,996 | +117.5% | 0.01% | +100.0% |
Q1 2016 | $917,000 | -18.9% | 26,200 | 0.0% | 0.00% | -20.0% |
Q4 2015 | $1,131,000 | -72.5% | 26,200 | -76.1% | 0.01% | -72.2% |
Q3 2015 | $4,108,000 | -23.7% | 109,600 | -30.5% | 0.02% | -18.2% |
Q2 2015 | $5,381,000 | -25.9% | 157,700 | -28.2% | 0.02% | -26.7% |
Q1 2015 | $7,257,000 | +104.5% | 219,700 | +110.8% | 0.03% | +87.5% |
Q4 2014 | $3,549,000 | -10.5% | 104,200 | +1.4% | 0.02% | -15.8% |
Q3 2014 | $3,965,000 | -35.7% | 102,800 | -35.1% | 0.02% | -34.5% |
Q2 2014 | $6,169,000 | +47.1% | 158,500 | +29.2% | 0.03% | +38.1% |
Q1 2014 | $4,195,000 | +75.4% | 122,700 | +7.6% | 0.02% | +75.0% |
Q4 2013 | $2,392,000 | -37.3% | 114,000 | -29.8% | 0.01% | -42.9% |
Q3 2013 | $3,814,000 | -43.7% | 162,300 | -35.6% | 0.02% | -46.2% |
Q2 2013 | $6,777,000 | – | 252,200 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |